Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 424B3 Offering Prospectus
  2. 424B3 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. 424B3 Offering Prospectus
  5. 8-K Event Executive or director change
  6. 8-K Event Material agreement · Unregistered share sale · Other events
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 10-Q Report Quarterly Report
  10. 4 Option exercise Director acquired 18,300 shares (option exercise)
  11. 4 Gift 10% owner gave 869,188 shares (gift)
  12. 4 Open-market sale General Counsel & Secretary sold 33,715 shares at $13.11 ($442,004)
  13. 4 Open-market sale Chief Comm. & Patient Officer sold 40,000 shares at $11.76 ($470,400)
  14. 3 Insider Initial Statement of Ownership
  15. SC 13D/A Stake Beneficial Ownership Report
  16. 424B3 Offering Prospectus
  17. 424B3 Offering Prospectus
  18. 8-K Event Material agreement · Other events
  19. 424B3 Offering Prospectus
  20. 424B3 Offering Prospectus

Page 14 of 24 · 479 filings